Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008
Roisín M. Connolly(Johns Hopkins University), Saraswati Sukumar(Johns Hopkins University), Xian Zhou(The University of Texas Health Science Center at Houston), Edward Gabrielson(Johns Hopkins University), Judy C. Boughey(Mayo Clinic in Arizona), Anna Maria Storniolo(Indiana University Health), Mary Jo Fackler(Sidney Kimmel Comprehensive Cancer Center), Vered Stearns(Johns Hopkins University), Bridget A. Walsh(Johns Hopkins University), Zhe Zhang(Children's Hospital of Philadelphia), Stanley P. Watkins(Anne Arundel Medical Center), John T. Carpenter(University of Louisville Hospital), Matthew P. Goetz(Mayo Clinic)
Cited by 18
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947